Rocket Pharmaceuticals Inc (RCKT)
22.91
-0.29
(-1.25%)
USD |
NASDAQ |
May 07, 13:13
Rocket Pharmaceuticals Cash and Short Term Investments (Quarterly): 373.18M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 373.18M |
| September 30, 2023 | 437.17M |
| June 30, 2023 | 307.04M |
| March 31, 2023 | 331.08M |
| December 31, 2022 | 356.39M |
| September 30, 2022 | 306.53M |
| June 30, 2022 | 321.37M |
| March 31, 2022 | 346.59M |
| December 31, 2021 | 388.74M |
| September 30, 2021 | 421.46M |
| June 30, 2021 | 426.83M |
| March 31, 2021 | 466.35M |
| December 31, 2020 | 482.72M |
| September 30, 2020 | 228.69M |
| June 30, 2020 | 249.80M |
| March 31, 2020 | 275.90M |
| December 31, 2019 | 304.12M |
| September 30, 2019 | 240.56M |
| June 30, 2019 | 257.78M |
| March 31, 2019 | 196.59M |
| Date | Value |
|---|---|
| December 31, 2018 | 205.73M |
| September 30, 2018 | 127.48M |
| June 30, 2018 | 132.10M |
| March 31, 2018 | 182.70M |
| December 31, 2017 | 100.01M |
| September 30, 2017 | 103.12M |
| June 30, 2017 | 108.75M |
| March 31, 2017 | 114.70M |
| December 31, 2016 | 126.47M |
| September 30, 2016 | 137.58M |
| June 30, 2016 | 98.22M |
| March 31, 2016 | 102.26M |
| December 31, 2015 | 111.28M |
| September 30, 2015 | 118.36M |
| June 30, 2015 | 49.01M |
| March 31, 2015 | 53.14M |
| December 31, 2014 | 3.618M |
| September 30, 2014 | 7.357M |
| December 31, 2013 | 12.79M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
228.69M
Minimum
Sep 2020
482.72M
Maximum
Dec 2020
343.28M
Average
331.08M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| ADMA Biologics Inc | 51.35M |
| Geron Corp | 443.05M |
| Madrigal Pharmaceuticals Inc | 634.13M |
| Ligand Pharmaceuticals Inc | 170.31M |
| Puma Biotechnology Inc | 107.16M |